Nahal Masrour
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Clinical validation of a DNA methylation biomarker associated with overall survival of relapsed ovarian cancer patients.
Journal: International journal of cancer
Published: June 26, 2025
Epigenetic potentiation of somatostatin-2 by guadecitabine in neuroendocrine neoplasias as a novel method to allow delivery of peptide receptor radiotherapy.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 01, 2022
Phase 1, dose-escalation study of guadecitabine (SGI-110) in combination with pembrolizumab in patients with solid tumors.
Journal: Journal for immunotherapy of cancer
Published: March 15, 2022
MicroRNA-495/TGF-β/FOXC1 axis regulates multidrug resistance in metaplastic breast cancer cells.
Journal: Biochemical pharmacology
Published: April 30, 2021
Oncogenic EP300 can be targeted with inhibitors of aldo-keto reductases.
Journal: Biochemical pharmacology
Published: January 15, 2019
Clinical translation of [18F]ICMT-11 for measuring chemotherapy-induced caspase 3/7 activation in breast and lung cancer.
Journal: European journal of nuclear medicine and molecular imaging
Published: January 16, 2018
Genes Predisposed to DNA Hypermethylation during Acquired Resistance to Chemotherapy Are Identified in Ovarian Tumors by Bivalent Chromatin Domains at Initial Diagnosis.
Journal: Cancer research
Published: June 06, 2017
Platinum-Based Chemotherapy Induces Methylation Changes in Blood DNA Associated with Overall Survival in Patients with Ovarian Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 11, 2016
Promoter CpG island methylation of genes in key cancer pathways associates with clinical outcome in high-grade serous ovarian cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 23, 2013
Loss of O⁶-methylguanine-DNA methyltransferase confers collateral sensitivity to carmustine in topoisomerase II-mediated doxorubicin resistant triple negative breast cancer cells.
Journal: Biochemical pharmacology
Published: September 07, 2012
The DNA methylomes of serous borderline tumors reveal subgroups with malignant- or benign-like profiles.
Journal: The American journal of pathology
Published: August 16, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026